New Edge Advisors, LLC Organovo Holdings, Inc. Transaction History

New Edge Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.06 - $1.9 $106 - $190	-100 Reduced 50.0%	100 $0
Q2 2023 Aug 14, 2023	SELL	$1.64 - $2.24 $328 - $448	-200 Reduced 50.0%	200 $0
Q1 2023 May 12, 2023	SELL	$1.44 - $3.2 $14 - $32	-10 Reduced 2.44%	400 $0
Q4 2022 Feb 14, 2023	BUY	$1.41 - $2.17 $578 - $889	410 New	410 $0

2.44M

17K

Ticker ONVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,712,020
Market Cap $2.96M
Description
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.